| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/18/2009 | US7575752 Immunogenic polypeptide for protecting pigs against viral infection or postweaning multisystemic wasting syndrome |
| 08/18/2009 | US7575750 Antifusogenic; antiviral conjugates; point mutations |
| 08/18/2009 | US7575749 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 08/18/2009 | US7575745 Ligand for herpes simplex virus entry mediator and methods of use |
| 08/18/2009 | US7575742 Method of treating autoimmune diseases with interferon-beta and IL-2R antagonist |
| 08/18/2009 | US7575741 Using interleukin-23 modulators to enhance wound healing |
| 08/18/2009 | US7575577 Devices and methods for the restoration of a spinal disc |
| 08/18/2009 | CA2577233C Pharmaceutical composition containing angiotensin ii antagonist |
| 08/18/2009 | CA2440710C Medicine of post-traumatic stress disorder |
| 08/18/2009 | CA2431813C Assay for anti-viral agent |
| 08/18/2009 | CA2429270C Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition |
| 08/18/2009 | CA2404616C Use of vegf and homologues to treat neuron disorders |
| 08/18/2009 | CA2388731C Pharmaceutical products and methods of fabrication therefor |
| 08/18/2009 | CA2369444C Pharmaceutical compositions of erythropoietin |
| 08/18/2009 | CA2288215C Use of immunomodulating agents |
| 08/18/2009 | CA2230240C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 08/18/2009 | CA2224008C The treatment of hiv and other viral infections using combinatorial therapy |
| 08/18/2009 | CA2223691C Tumor- or cell-specific herpes simplex virus replication |
| 08/18/2009 | CA2215697C Stable polymerized hemoglobin blood-substitute |
| 08/18/2009 | CA2184841C Recombinant adenovirus coding for glial-derived neurotrophic factor (gdnf) |
| 08/18/2009 | CA2174526C Pseudodipeptide product possessing an imidazole group and the therapeutic, cosmetological and agri-food applications of the said product |
| 08/18/2009 | CA2165203C Immunoglobulin g concentrate for therapeutic use and method for producing same |
| 08/18/2009 | CA2124059C Octacyclodepsipeptides having an endoparasiticidal action |
| 08/18/2009 | CA2105552C Soluble ligands for cd40 |
| 08/13/2009 | WO2009100456A2 Inhibition and treatment of gastrointestinal biofilms |
| 08/13/2009 | WO2009100454A1 Compositions and methods for distraction osteogenesis |
| 08/13/2009 | WO2009100445A2 Compositions and methods which modulate g-protein signaling for the treatment of asthma |
| 08/13/2009 | WO2009100363A2 Methods for preventing or treating insulin resistance |
| 08/13/2009 | WO2009100348A2 Peptides and peptide mimetics to treat pathologies associated with eye disease |
| 08/13/2009 | WO2009100225A1 Inhibitors of cathepsin b |
| 08/13/2009 | WO2009100222A1 Non-polymeric compositions for controlled drug delivery |
| 08/13/2009 | WO2009100218A2 Kruppel-like transcription factor klf4/gklf and uses thereof |
| 08/13/2009 | WO2009100216A1 Composition for sustained release delivery of proteins or peptides |
| 08/13/2009 | WO2009100127A2 Isolated brca1 peptides and method of use |
| 08/13/2009 | WO2009100065A2 Method of removing undesired tissue from connective tissue |
| 08/13/2009 | WO2009100037A1 Methods for treating a condition characterized by dysfunction in protein homeostasis |
| 08/13/2009 | WO2009100035A2 Interleukin-21 (il-21) and il-21 receptor (il-21r) modulation of regulatory t cells and forkhead box p3 (foxp3) |
| 08/13/2009 | WO2009099777A2 Chimeric hiv fusion proteins as vaccines |
| 08/13/2009 | WO2009099763A1 Ester-based peptide prodrugs |
| 08/13/2009 | WO2009099679A2 Treatment of disease conditions via administration of dna repair enzyme |
| 08/13/2009 | WO2009099677A2 Therapeutic peptidomimetic macrocycles |
| 08/13/2009 | WO2009099642A2 Proteomic analysis of active multiple sclerosis lesions |
| 08/13/2009 | WO2009099467A2 Cyclosporin compositions |
| 08/13/2009 | WO2009099444A1 Nutritional formula for athletes' recovery |
| 08/13/2009 | WO2009099416A1 Heterocyclic peptide ketoamides |
| 08/13/2009 | WO2009099316A1 Use of lipid-rich nutrition for the treatment of post-operative ileus |
| 08/13/2009 | WO2009099132A1 Method for improving storage stability of glutathione |
| 08/13/2009 | WO2009098901A1 3,8-diaminotetrahydroquinoline derivative |
| 08/13/2009 | WO2009098707A1 A method of purifying a peptide |
| 08/13/2009 | WO2009098701A1 Siva 2 stabilization |
| 08/13/2009 | WO2009098700A1 Siva 3, its preparation and use |
| 08/13/2009 | WO2009098690A2 Novel fer -like protein, pharmaceutical compositions containing it and method for its use |
| 08/13/2009 | WO2009098577A2 Non-immunosuppressive cyclosporin for the treatment of muscular dystrophy |
| 08/13/2009 | WO2009098533A1 Non -immunosuppressive cyclosporin for the treatment of muscular dystrophy |
| 08/13/2009 | WO2009098492A2 Modulation of adenoviral tropism |
| 08/13/2009 | WO2009098454A2 Treatment of diseases and conditions mediated by eicosanoids |
| 08/13/2009 | WO2009098344A1 Compositions and methods for modulating p300 activity |
| 08/13/2009 | WO2009098318A1 Liquid formulation of fsh |
| 08/13/2009 | WO2009097691A1 USE OF P27kip1 FOR THE PREVENTION AND TREATMENT OF HEART FAILURE |
| 08/13/2009 | WO2009081274A3 Mutant forms of streptolysin o |
| 08/13/2009 | WO2009071903A3 Composition comprising a chondroitin sulphate proteoglycan inhibitory agent and an anti-inflammatory agent |
| 08/13/2009 | WO2009067191A3 Methods and compositions for the treatment of hepatitis c virus (hcv) infection |
| 08/13/2009 | WO2009062260A8 Therapy for multiple sclerosis |
| 08/13/2009 | WO2009047513A3 Antagonists of kisspeptin and uses thereof |
| 08/13/2009 | WO2009044173A3 Methods of treating cancer using notch pathway inhibitors |
| 08/13/2009 | WO2009043525A3 Use of the combination of gluten exorphin c and cd36 as a therapeutic agent |
| 08/13/2009 | WO2009043477A3 Use of glpl (7-36) alone or in combination with leptin 22-56 as a therapeutic agent |
| 08/13/2009 | WO2009043453A3 Use of a peptide as a therapeutic agent |
| 08/13/2009 | WO2009043436A3 Use of af12198 as a therapeutic agent |
| 08/13/2009 | WO2009040031A3 Use of a peptide as a therapeutic agent |
| 08/13/2009 | WO2009039991A3 Use of aviptadil as a therapeutic agent |
| 08/13/2009 | WO2009039964A3 Use of glucagon-like peptide as a therapeutic agent |
| 08/13/2009 | WO2009033792A3 Gamma 1 msh alone or in combination with pentagastrin as a therapeutic agent |
| 08/13/2009 | WO2009019534A3 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| 08/13/2009 | WO2009018175A3 Cyclic azapeptides as integrin markers |
| 08/13/2009 | WO2009005798A3 Antifungal formulation and method of preparation |
| 08/13/2009 | WO2008148839A3 Long-acting polymeric prodrugs of exendin |
| 08/13/2009 | WO2008143880A8 Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and traumatic brain injury |
| 08/13/2009 | WO2008098364A8 Reducing post-operative adhesion formation with intraperitoneal glutamine |
| 08/13/2009 | WO2008073448A3 Pharmaceutical formulations and methods for making the same |
| 08/13/2009 | WO2008071081A8 Preparation of low bleeding anticoagulant fusion protein and its use |
| 08/13/2009 | WO2007033211A3 Regulation of brain natriuretic peptide and catecholamines for the treatment of cardiovascular diseases |
| 08/13/2009 | WO2006085979A9 Soluble forms of hendra and nipah virus g glycoprotein |
| 08/13/2009 | WO2003003984A8 Novel proteins and nucleic acids encoding same |
| 08/13/2009 | US20090205068 Method for Producing Genetically Modified Plant Expressing Miraculin |
| 08/13/2009 | US20090205062 Caspase-9 deficient animals and the use thereof |
| 08/13/2009 | US20090205058 Genetically modified non-human mammals and cells |
| 08/13/2009 | US20090204489 Biological markers predictive of rheumatoid arthritis response to b-cell antagonists |
| 08/13/2009 | US20090204204 Drug/Drug Deliver Systems For The Prevention And Treatment Of Vascular Disease |
| 08/13/2009 | US20090204189 Living-Tissue Normalization Method |
| 08/13/2009 | US20090203878 Tryptophan as a functional replacement for adp-ribose-arginine in recombinant proteins |
| 08/13/2009 | US20090203842 Macromolecular Conjugates And Processes For Preparing The Same |
| 08/13/2009 | US20090203803 N-acylated chitinous polymers and methods of use thereof |
| 08/13/2009 | US20090203768 Nucleic acid-containing complex |
| 08/13/2009 | US20090203767 Inhibition stat-1 |
| 08/13/2009 | US20090203760 CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS |
| 08/13/2009 | US20090203719 Enhancing treatment of mdr cancer with adenosine a3 antagonists |
| 08/13/2009 | US20090203633 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 08/13/2009 | US20090203631 Peptide deformylase inhibitors as novel antibiotics |
| 08/13/2009 | US20090203630 Process for preparing atazanavir bisulfate and novel forms |